Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping

被引:30
作者
Caserta, Donatella [1 ]
Adducchio, Gloria [1 ]
Picchia, Simona [1 ]
Ralli, Eleonora [1 ]
Matteucci, Eleonora [1 ]
Moscarini, Massimo [1 ]
机构
[1] Univ Roma La Sapienza, St Andrea Hosp, Dept Gynecol Obstet & Urol Sci, Via Grottarossa 1035-1039, I-00189 Rome, Italy
关键词
BMI; HOMA; lifestyle; metabolic syndrome; PCOS; therapy; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE MODIFICATION; INSULIN-RESISTANCE; WEIGHT-LOSS; OBESITY; OMEGA-3-FATTY-ACIDS; INFLAMMATION; METAANALYSIS; DISEASE; HYPERTENSION;
D O I
10.3109/09513590.2014.887673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metabolic syndrome is an increasing pathology in adults and in children, due to a parallel rise of obesity. Sedentary lifestyle, food habits, cultural influences and also a genetic predisposition can cause dyslipidemia, hypertension, abdominal obesity and insulin resistance which are the two main features of metabolic syndrome. Polycystic ovary syndrome (PCOS) is a condition directly associated with obesity, insulin resistance (HOMA index) and metabolic syndrome, and it is very interesting for its relationship and overlap with the metabolic syndrome. The relationship between the two syndromes is mutual: PCOS women have a higher prevalence of metabolic syndrome and also women with metabolic syndrome commonly present the reproductive/endocrine trait of PCOS. Prevention and treatment of metabolic syndrome and PCOS are similar for various aspects. It is necessary to treat excess adiposity and insulin resistance, with the overall goals of preventing cardiovascular disease and type 2 diabetes and improving reproductive failure in young women with PCOS. First of all, lifestyle changes, then pharmacological therapy, bariatric surgery and laparoscopic ovarian surgery represent the pillars for PCOS treatment.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 62 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]   An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries [J].
Amer, SAKS ;
Li, TC ;
Bygrave, C ;
Sprigg, A ;
Saravelos, H ;
Cooke, ID .
HUMAN REPRODUCTION, 2002, 17 (06) :1616-1622
[3]  
[Anonymous], OV OB BAS CHILDH OB
[4]  
[Anonymous], 2011, HLTH WEIGHT ITS NOT
[5]  
[Anonymous], 2006, CLOM CLOM
[6]  
Ashley N., 2009, DOES AFRICAN AM CULT
[7]   Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[8]   Treatment options for polycystic ovary syndrome [J].
Badawy, Ahmed ;
Elnashar, Abubaker .
INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2011, 3 :25-35
[9]   Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial [J].
Banaszewska, Beata ;
Pawelczyk, Leszek ;
Spaczynski, Robert Z. ;
Duleba, Antoni J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) :4938-4945
[10]   Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy [J].
Barnett, AH ;
Bain, SC ;
Bouter, P ;
Karlberg, B ;
Madsbad, S ;
Jervell, J ;
Mustonen, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1952-1961